Fig. 2
From: A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2
The Correlation between SHOX2 expression and survival prognosis in various types of cancer based TCGA database. A Survival maps of overall survival (OS) and disease-free survival (DFS) (B) between high and low SHOX2 expression in different types of cancer compared using a log-rank test via GEPIA2. C The correlation between SHOX2 expression and prognosis of glioma patients in TCGA, CGGA and GSE16011 datasets